100 related articles for article (PubMed ID: 8797264)
1. Determination of growth fraction index in mammary carcinoma using MIB-1 monoclonal antibody: estimation of whole tumor proliferative potential using biopsy specimens.
Oda K; Yokoi S; Kanda H; Shibuya M; Kamiya S; Horisawa M; Niinomi N; Suzuki M; Hayakawa S; Kishikawa S
Tokai J Exp Clin Med; 1995 Jul; 20(2):81-8. PubMed ID: 8797264
[TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical assessment of proliferation rate of breast carcinoma cells using Ki-67, MIB-1 and anti-PCNA monoclonal antibodies.
Markiewski M; Domagała W
Pol J Pathol; 1996; 47(4):189-94. PubMed ID: 9097711
[TBL] [Abstract][Full Text] [Related]
3. Correlation between MIB-1 and other proliferation markers: clinical implications of the MIB-1 cutoff value.
Spyratos F; Ferrero-Poüs M; Trassard M; Hacène K; Phillips E; Tubiana-Hulin M; Le Doussal V
Cancer; 2002 Apr; 94(8):2151-9. PubMed ID: 12001111
[TBL] [Abstract][Full Text] [Related]
4. [Comparative studies on the biological significance of the marker for proliferation Ki-67-Antigen and PCNA in primary ovarian carcinoma].
Reitmaier M; Rudlowski C; Biesterfeld S; Rath W; Schröder W
Zentralbl Gynakol; 2000; 122(7):361-7. PubMed ID: 10951706
[TBL] [Abstract][Full Text] [Related]
5. [Ki 67 growth fraction in carcinomas and benign lesions of the breast].
Kunz J; Schmidt A
Zentralbl Pathol; 1993 Aug; 139(3):201-5. PubMed ID: 8218121
[TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of a formalin-resistant nuclear proliferation antigen in mammary carcinomas as determined by the monoclonal antibody Ki-S1.
Kreipe H; Alm P; Olsson H; Hauberg M; Fischer L; Parwaresch R
Am J Pathol; 1993 Feb; 142(2):651-7. PubMed ID: 8094598
[TBL] [Abstract][Full Text] [Related]
7. A technique for automatic/interactive assessment of the proliferating fraction of neoplastic cells in solid tumors. A methodological study on the Ki-67 immunoreactive cells in human mammary carcinomas, including a comparison with the results of conventional S-phase fraction assessments by means of DNA cytometry.
Parrado C; Falkmer UG; Höög A; Falkmer S; Ahrens O; Rius F; Grimelius L
Gen Diagn Pathol; 1996 Mar; 141(3-4):215-27. PubMed ID: 8705786
[TBL] [Abstract][Full Text] [Related]
8. [Detection of Ki-67 in liver biopsy specimens using monoclonal antibody to Mib-1].
Matsumoto K; Tanimoto K; Michitaka K; Furutani T; Nakaya M; Horiike N; Onji M
Rinsho Byori; 1999 Oct; 47(10):956-60. PubMed ID: 10590670
[TBL] [Abstract][Full Text] [Related]
9. Assessment of the expression of p53, MIB-1 (Ki-67 antigen), and argyrophilic nucleolar organizer regions in carcinoma of the extrahepatic bile duct.
Suto T; Sugai T; Nakamura S; Funato O; Nitta H; Sasaki R; Kanno S; Saito K
Cancer; 1998 Jan; 82(1):86-95. PubMed ID: 9428483
[TBL] [Abstract][Full Text] [Related]
10. Mammaglobin and CRxA-01 in pleural effusion cytology: potential utility of distinguishing metastatic breast carcinomas from other cytokeratin 7-positive/cytokeratin 20-negative carcinomas.
Ciampa A; Fanger G; Khan A; Rock KL; Xu B
Cancer; 2004 Dec; 102(6):368-72. PubMed ID: 15558786
[TBL] [Abstract][Full Text] [Related]
11. High growth fraction at 9 grays of radiotherapy is associated with a good prognosis for patients with cervical squamous cell carcinoma.
Oka K; Suzuki Y; Nakano T
Cancer; 2000 Oct; 89(7):1526-31. PubMed ID: 11013367
[TBL] [Abstract][Full Text] [Related]
12. Comparison of quantitative and semiquantitative methods of assessing MIB-1 with the S-phase fraction in breast carcinoma.
MacGrogan G; Jollet I; Huet S; Sierankowski G; Picot V; Bonichon F; Coindre JM
Mod Pathol; 1997 Aug; 10(8):769-76. PubMed ID: 9267818
[TBL] [Abstract][Full Text] [Related]
13. [Immunohistochemical study of breast neoplasms cells using different markers of proliferation].
Uporov AV; Semiglazov VF; Pozharisskiĭ KM
Arkh Patol; 2000; 62(2):26-30. PubMed ID: 10789010
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of tumor cell proliferation rate as determined by the MIB-1 antibody in breast carcinoma: its relationship with vimentin and p53 protein.
Domagala W; Markiewski M; Harezga B; Dukowicz A; Osborn M
Clin Cancer Res; 1996 Jan; 2(1):147-54. PubMed ID: 9816101
[TBL] [Abstract][Full Text] [Related]
15. Multi-parameter flow cytometric analysis with detection of the Ki67-Ag in paraffin embedded mammary carcinomas.
Leers MP; Theunissen PH; Ramaekers FC; Schutte B
Cytometry; 1997 Mar; 27(3):283-9. PubMed ID: 9041118
[TBL] [Abstract][Full Text] [Related]
16. Clinical significance of double staining of MIB-1 and AgNORs in primary breast carcinoma.
Kidogawa H; Nanashima A; Yano H; Matsumoto M; Yasutake T; Nagayasu T
Anticancer Res; 2005; 25(6B):3957-62. PubMed ID: 16309183
[TBL] [Abstract][Full Text] [Related]
17. [Ki-67 in carcinoma of the breast: from the frozen to the paraffin sections].
Ghidoni D; Folicaldi S; Errani E; Borgini B; Bondi A
Pathologica; 1996 Aug; 88(4):270-4. PubMed ID: 9005395
[TBL] [Abstract][Full Text] [Related]
18. Proliferative, infiltrative, and metastatic activities in colorectal tumors assessed by MIB-1 antibody.
Ishida H; Sadahiro S; Suzuki T; Ishikawa K; Kamijo A; Tajima T; Makuuchi H; Murayama C
Oncol Rep; 2003; 10(6):1741-5. PubMed ID: 14534689
[TBL] [Abstract][Full Text] [Related]
19. Different antigen unmasking techniques lead to significant differences in immunohistochemical staining of Ki-67 (Mib-1) in renal cell carcinomas.
Heuschmid M; Hofmockel G; Dexler B; Dämmrich J; Bassukas ID
Oncol Rep; 2002; 9(1):19-22. PubMed ID: 11748449
[TBL] [Abstract][Full Text] [Related]
20. Cell proliferation in feline normal, hyperplastic and neoplastic mammary tissue--an immunohistochemical study.
Dias Pereira P; Carvalheira J; Gärtner F
Vet J; 2004 Sep; 168(2):180-5. PubMed ID: 15301767
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
